Daxor - DXR Company Value to Revenue

Official company branding of Daxor Corp (DXR)

Daxor Corporation (DXR) demonstrates high macroeconomic resilience driven by stable demand for cardiology diagnostics. Business efficiency relies on contract component assembly and global service. An impeccable brand image confirms its status as a benchmark for precision. The enterprise value-to-revenue ratio on the GURU.Markets chart helps assess the company's fundamentals, while the 274400.00 level captures the current state of the metric.

DXR daxor.com Enterprise Value-to-Revenue Ratio (11/23/2025 - 11/20/2026)

Daxor Corp. - analytical breakdowns and key metrics (DXR)

- market price and analyst price targets:
Initial company analysis:DXR Daxor Corporation
Product sample of Daxor Corp

When screening assets, an investor determines the fair value of a business by excluding distortions caused by debt load. This metric compares the total enterprise value to annual revenue, which for Daxor Corporation (DXR), whose diagnostic systems are in high demand within the stable healthcare sector, allows for the filtering of market noise. The EV/Sales trend for Daxor Corporation clearly demonstrates the extent to which current capitalization aligns with real demand for cardiology technologies.